Optimising the management of allergic rhinitis: an Australian perspective

@article{Walls2005OptimisingTM,
  title={Optimising the management of allergic rhinitis: an Australian perspective},
  author={Ronald S. Walls and Robert J. Heddle and Mimi L. K. Tang and Benjamin Joseph Basger and Graham O. Solley and Guan T. Yeo},
  journal={Medical Journal of Australia},
  year={2005},
  volume={182}
}
Allergic rhinitis (AR) is one of the most prevalent medical conditions. It has significant effects on quality of life and can have considerable socioeconomic effects. The traditional classification of perennial and seasonal rhinitis does not distinguish between provoking factors, nor does it indicate the most appropriate treatment. A more useful classification is based on symptoms, which may be intermittent or persistent, and vary widely in severity. The goal of management is to achieve optimal… 

Allergic rhinitis - practical management strategies.

Practical strategies and evidence based management of allergic rhinitis are outlined, including patient education, intranasal steroids and immunotherapy ('desensitisation'), and general practitioners play a vital role in all three strategies.

Keys to successful management of patients with allergic rhinitis: Focus on patient confidence, compliance, and satisfaction

  • B. MarpleJ. Fornadley P. Penna
  • Medicine
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • 2007

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs.

Allergic rhinoconjunctivitis in the Australian population: Burden of disease and attitudes to intranasal corticosteroid treatment

The burden of AR/C is examined and use of, and attitudes, to INCS sprays in the Australian population is explored and it is concluded that improvement in diagnosis, management, and patient education is needed.

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

Strategies for the management of intermittent allergic rhinitis: an Australian study

The range and proportion of symptoms and triggers experienced by patients with intermittent allergic rhinitis are examined and a qualitative analysis of strategies devised to control Symptoms and triggers are conducted.

Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis

These guidelines have been prepared in line with existing international guidelines to provide evidence-based recommendations for the diagnosis and management of AR in China and have been developed by the Chinese Society of Allergy to be accessible to both national and international medical communities involved in the Management of AR patients.

A patient-centric analysis to identify key influences in allergic rhinitis management

By mapping the AR network, this study demonstrated that there are multiple influences behind patient’s decisions regarding AR management but the role of the HCP cannot be dismissed.

Healthcare professional versus patient goal setting in intermittent allergic rhinitis.

Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases

The significant burden posed on community pharmacy to address the needs of people with rhinitis symptoms is highlighted, and the failure to translate the evidence that INCSs are the most effective monotherapy for moderate to severe and/or persistentRhinitis into clinical practice in light of the lack of evidence supporting combination of INCS and OAH therapy is highlighted.

References

SHOWING 1-10 OF 39 REFERENCES

Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines.

Evidence tables demonstrated that in all studies in which total nasal symptoms and nasal obstruction were recorded, the nasal steroid was statistically superior to the nonsedating antihistamine.

Consensus statement * on the treatment of allergic rhinitis

Current guidelines emphasize the importance of an accurate diagnosis of patients presenting with rhinitis symptoms and the morbidity of SAR obviously depends on the geographic region, the pollen season of the plants, and the local climate.

Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis.

  • A. YáñezG. Rodrigo
  • Medicine
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 2002

Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.

A 1-year study of prepubertal patients between 3 and 9 years of age with perennial allergic rhinitis was conducted to assess the effects on growth of mometasone furoate aqueous nasal spray, a new once-daily intranasal corticosteroid with negligible bioavailability.

House dust mite avoidance measures for perennial allergic rhinitis: a systematic review of efficacy.

  • A. SheikhB. Hurwitz
  • Medicine
    The British journal of general practice : the journal of the Royal College of General Practitioners
  • 2003
It is indicated that significant reductions of allergen load can be achieved by physical and chemical means, but there is little evidence at present that these reductions translate into sustained improvements in clinical outcomes.

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.

In patients with seasonal allergic rhinitis, intranasal glucocorticoids are more effective than an antileukotriene drug or combined antilesinophils-antihistamine for the reduction of pollen-induced nasal eosinophilic inflammation and for control of nasal symptoms.

The effect of treatment of allergic rhinitis on asthma morbidity, including emergency department visits

Effective management of allergic rhinitis with nasal steroids and possibly oral antihistamines reduces utilization of acute health care services due to asthma among persons with co-existent asthma.

The burden of allergic rhinitis: beyond dollars and cents.

  • S. Fineman
  • Medicine
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 2002

Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology.

  • M. DykewiczS. Fineman D. Schuller
  • Medicine
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 1998

Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial

The aim of the study was to validate the guidelines of the International Consensus on Rhinitis in the treatment of seasonal allergic rhinitis.